How can Humors Tech revolutionize healthcare with its Rs 2Cr investment from Venture Catalysts?

Healthtech startup Humors Tech secures Rs 2 crore in pre-seed funding round from Venture Catalysts, enabling the company to launch commercially, conduct clinical validation studies, and expand globally with its flagship product, Respyr. Respyr, a breath-based health screening device, promises to transform early disease detection and health monitoring.

What’s the Goal of the Fundraising?

The aim of the fundraising drive is multifaceted, with a primary focus on three key areas: bolstering Respyr’s commercial launch, conducting pivotal clinical validation studies, and extending its reach into international markets.

Humors Tech intends to harness this capital infusion to ensure widespread availability and functionality of Respyr across various healthcare environments.

Furthermore, the objective is to seamlessly integrate Respyr into popular fitness applications and wearable devices, enhancing health monitoring capabilities and enabling prompt medical interventions.

What Does Respyr Offer?

Respyr harnesses a blend of Artificial Intelligence (AI), the Internet of Things (IoT), and patented biomarker analysis to identify and track a range of health conditions such as diabetes, hypertension, heart, liver, kidney, and respiratory issues.

This innovative health screening tool transitions healthcare from reactive to proactive, aiming to intervene before diseases exert significant effects. Users can effortlessly monitor their health by exhaling into the device, which analyzes distinct biomarker patterns and delivers detailed health insights through a mobile app, accompanied by actionable recommendations for enhancing well-being.

What are the Possible Uses of Respyr?

Humors Tech functions under a dual B2B and B2B2C model, serving corporates, insurers, government hospitals, remote healthcare facilities, and consumers alike. Respyr presents diverse applications for employee wellness initiatives, insurance involvement, streamlined medical assessments, and rural healthcare accessibility.

This wide-ranging utility positions Respyr to tap into a significant total addressable market (TAM) of 612 million individuals in India, initially targeting a serviceable available market (SAM) of 163 million health-conscious individuals.

Who Are the Founders of Humors Tech?

Humors Tech, established in 2021 by Ankur Jaiswal, Suchita Mulye Kanaldekar, Pushkar Bhagwat, and Kushal Vyas, is headquartered in Bangalore, Karnataka.

The founding team envisions integrating AI, deep tech, and IoT into clinical research, culminating in innovative and user-centric healthcare platforms.

Ankur Jaiswal, Founder of Humors Tech, elaborates, “Most healthcare research today is reactive; intervening after diseases have already caused substantial impact. Through Respyr, we aim to revolutionize the very premise of healthcare, making it proactive, accessible, and personalized for each individual.”